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Abstract
Background: This study evaluated the exposure of dogs to three different Ehrlichia spp. in the south and central
regions of the United States where vector-borne disease prevalence has been previously difficult to ascertain,
particularly beyond the metropolitan areas.
Methods: Dog blood samples (n = 8,662) were submitted from 14 veterinary colleges, 6 private veterinary
practices and 4 diagnostic laboratories across this region. Samples were tested for E. canis, E. chaffeensis and
E. ewingii specific antibodies using peptide microtiter ELISAs.
Results: Overall, E. canis, E. chaffeensis and E. ewingii seroprevalence was 0.8%, 2.8%, and 5.1%, respectively. The
highest E. canis seroprevalence (2.3%) was found in a region encompassing Arkansas, Louisiana, Oklahoma,
Tennessee and Texas. E. chaffeensis seroreactivity was 6.6% in the central region (Arkansas, Kansas, Missouri, and
Oklahoma) and 4.6% in the southeast region (Georgia, Maryland, North Carolina, South Carolina, Tennessee and
Virginia). Seroreactivity to E. ewingii was also highest in the central region (14.6%) followed by the southeast region
(5.9%). The geospatial pattern derived from E. chaffeensis and E. ewingii seropositive samples was similar to previous
reports based on E. chaffeensis seroreactivity in white-tailed deer and the distribution of human monocytic
ehrlichiosis (HME) cases reported by the CDC.
Conclusions: The results of this study provide the first large scale regional documentation of exposure to E. canis,
E. chaffeensis and E. ewingii in pet dogs, highlighting regional differences in seroprevalence and providing the basis
for heightened awareness of these emerging vector-borne pathogens by veterinarians and public health agencies.
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Background
Dogs are susceptible to infection with multiple Ehrlichia
spp., including E. chaffeensis and E. ewingii,w h i c ha r e
predominantly transmitted by Amblyomma americanum
(lone star tick), and to E. canis,w h o s ep r i m a r yv e c t o ri s
considered to be Rhipicephalus sanguineus (brown dog
tick) [1-4]. Amblyomma americanum is commonly found
on dogs and people in the southeastern and southcentral
United States; indeed, human monocytic ehrlichiosis
caused by E. chaffeensis is the most frequently diagnosed
tick-borne disease in the southern U.S. [5,6]. The number
of human monocytic ehrlichiosis cases reported annually
has also risen steadily from 200 patients in the year 2000
to over 900 patients in 2009 [7,8]. Infections with
E. ewingii are also well documented in both dogs and
humans in the southeastern and southcentral U.S.
[4,9-12]. The geographic range of A. americanum has
expanded dramatically in recent decades to include many
areas of the Midwest and Northeast, resulting in a conco-
mitant increase in the regions at risk for autochthonous
transmission of E. chaffeensis and E. ewingii to dogs and
people [6,13]. Investigative field surveys have implicated
other tick species, including Dermacentor variabilis
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implicated as secondary vectors of E. chaffeensis and/or
E. ewingii [14-16], but the relative importance of these
ticks in maintaining a sustained cycle of infection in nat-
ure remains to be determined.
Rhipicephalus sanguineus ticks, the vectors for E. canis,
are also common in the warmer climates of the southern
U.S., due in part to their tropical or Mediterranean origin
and general intolerance of cold temperatures [17,18].
Brown dog ticks are thought to have been introduced to
the Americas, most likely on tick infested dogs from
Europe. Because this tick can survive inside dwellings
wherever dogs are present, R. sanguineus is now consid-
ered to be endemic throughout the U.S. with higher pre-
valence in particular geographic regions [19-21]. Brown
dog ticks are known or strongly suspected to transmit a
number of other pathogens to dogs in North America,
including Bartonella vinsonii subsp. berkhoffii, Rickettsia
rickettsii, Babesia canis, Hepatozoon canis,a n d
Anaplasma platys [17,22].
Diagnosis of an ehrlichial infection can be performed
using visual, serologic or molecular methods. Erhlichia
spp. replicate inside a membrane bound vacuole (i.e.,
morula) that can sometimes be observed by light micro-
scopic examination of stained blood smears inside either
monocytes (E. canis and E. chaffeensis) or granulocytes
(E. ewingii). Detection of antibodies can be performed
by immunofluorescent assay (IFA) or enzyme linked
immunosorbant assays (ELISA) but cross-reactivity
between antibodies to Ehrlichia species is possible [23].
Polymerase chain reaction (PCR) is the most common
molecular method used to diagnose an Ehrlichia spp.
infection, particularly in dogs with acute illness where
the onset of clinical signs may precede a measurable
antibody response.
Serologic surveys of dogs for exposure to tick-borne
pathogens have been used to identify areas where both
people and dogs are at risk of acquiring infection [24-28].
However, prospective surveys involving dogs have often
been limited to a small geographic region, such as a por-
tion of a single state [29-31]. Reports of large scale retro-
spective analyses may be skewed to areas with higher
human population density and thus higher pet dog den-
sity. However, these regions may not represent regions
with the highest tick exposure. For example, in a recent
publication describing exposure to common tick-borne
pathogens in nearly one million dogs from the U.S. [25],
only 6.4% of samples came from the states of Kansas,
Oklahoma, Missouri, Arkansas, Louisiana, and Missis-
sippi, where very dense populations of A. americanum
ticks are found. In addition, the majority of results
reported were from urban areas within the states. To
combat the bias inherent in such surveys and to better
document the prevalence of exposure to Ehrlichia spp. in
the south and central U.S., samples collected from dogs
presenting primarily to regional veterinary colleges were
tested for E. canis, E. chaffeensis and E. ewingii specific
antibodies. A better understanding of the distribution of
exposure to these three ehrlichial agents in dogs will pro-
vide insight into areas where people and dogs are at
greatest risk of infection.
Methods
Canine Serum Samples
A total of 8,662 canine serum samples were collected from
14 veterinary colleges, 4 commercial diagnostic laboratory
locations and 6 private veterinary practices. Participating
veterinary colleges included Auburn University, University
of Florida, University of Georgia, University of Illinois,
Kansas State University, Louisiana State University (LSU),
Mississippi State University, University of Missouri, North
Carolina State University (NCSU), The Ohio State Univer-
sity, Oklahoma State University (OKSU), Purdue Univer-
sity, University of Tennessee, and Texas A&M University
(TAMU). Participating commercial diagnostic laboratories
were located in Dallas, TX, Baltimore, MD, Totowa, NJ,
and North Grafton, MA. The private practices were
located in Arkansas, Missouri, North Carolina and Ten-
nessee. The majority of samples collected from veterinary
colleges and from all diagnostic laboratories consisted of
serum that remained after performance of requested diag-
nostic tests unrelated to this study. These samples were
chosen randomly, without regard to clinical signs or sus-
pected diagnosis, from among all remaining serum sam-
ples from dogs ≥ 6m o n t h so fa g e .S e r u ms a m p l e s
collected from dogs involved in shelter medicine programs
represented all samples from Texas A&M and 183/307
serum samples from Louisiana State University. Samples
submitted from NCSU included an equal number (250
each) of randomly chosen samples and samples previously
submitted to the NCSU Vector-Borne Disease Diagnostic
Laboratory (VBDDL) for serological testing. More than
half of the serum samples collected from OKSU (360/503)
were originally submitted for brucellosis testing. For sam-
ples submitted from private veterinary practices, a small
additional volume of blood (approximately 2 ml) was col-
lected with informed owner consent specifically for the
purposes of this study at the time of blood collection
related to routine veterinary care; sampled dogs were cho-
sen from the general population and not selected based on
particular clinical signs. Although most samples were col-
lected between January 2009 and October 2010, 250 sam-
ples from the NCSU-VBDDL were collected during the
first 6 months of 2006.
Data collection
Limited patient information was available for the sam-
ples. However, the date of sample collection, the dog’s
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the dog’s owner, veterinary hospital or shelter was
recorded. Neither breed nor gender of dogs was
recorded.
Serology
All serum samples were tested by 3 microtiter plate ELI-
SAs, each one using a species-specific peptide for the
detection of antibodies reactive to E. canis, E. chaffeensis
and E. ewingii. Synthetic peptides were derived from the
E. ewingii p28 protein (EESP), the E. canis p16 protein,
and the E. chaffeensis variable-length PCR target (VLPT)
protein [32,33]. Testing was performed as previously
described with minor modifications [32]. Samples were
initially screened on each of the 3 microtiter plate ELI-
SAs using an indirect assay protocol and confirmed using
the same peptide ELISA but with a peptide-labeled direct
assay. Briefly, in the indirect assay, diluted samples
(1:100) were incubated in each of the 3 species-specific
ELISA peptide-coated wells for 30 minutes, the wells
were washed (300 μL/well with PBS plus detergent), and
horseradish peroxidase-labeled anti-canine antibody
(1:1000 dilution in a diluent containing non-specific pro-
tein and detergent) was added to each well and incubated
for 30 minutes. Plates were washed as above, 3,3’,5,5’
teteramethylbenzidine (TMB) substrate solution (50 μL/
well) was added, and optical density was determined at
650 nm; reactive samples were denoted by any absor-
bance value > 2 times the negative control value. Reactive
samples were confirmed in duplicate by adding 50 ul of
the serum sample and 100 μL of a species-specific pep-
tide horseradish peroxidase conjugate (0.5 to 2.0 μg/mL
in diluent) to the microtiter-plate ELISA coated with the
species-specific peptide. This was allowed to incubate for
60 min, microtiter wells were then washed 6 times, incu-
bated with TMB substrate (100 μL/well) and read at 650
nm as described above.
Results for E. canis immunofluorescence assays (IFA)
were available for 249 samples from the VBDDL at
NCSU. Testing was performed following previously
d e s c r i b e ds t a n d a r dp r o c e dures of the VBDDL service
[34]. E. canis antigens (NCSU Jake strain) were grown in
vitro in DH82 cells by the VBDDL. Seropositive samples
were defined as having endpoint titers ≥64 using a dilu-
tion scale of 1:16 - 1:8192.
Analysis
Seroprevalence for each pathogen was determined by
county and state using zip code data of the patient, shel-
ter or veterinary practice submitting the sample. At least
50 samples were required from a state in order to calcu-
late seroprevalence as depicted in the maps. Seropreva-
lence results by county were calculated if at least 5
samples were obtained from a county. Geographic
regions for comparison of seroprevalence were deter-
mined according to the expected tick population pres-
sure. For seroprevalence of E. canis, which is transmitted
primarily by R. sanguineus, the region with the greatest
expected tick pressure was defined to include Alabama,
Arkansas, Florida, Georgia, Louisiana, Mississippi, North
Carolina, Oklahoma, South Carolina, Tennessee and
T e x a sa n dt h i sr e g i o nw a sc o mpared to all other states.
For seroprevalence of E. ewingii and E. chaffeensis,w h i c h
are transmitted primarily by A. americanum,t h er e g i o n s
expected to have the greatest A. americanum pressure
were defined as central (Arkansas, Kansas, Missouri, and
Oklahoma), or southeastern (Georgia, Maryland, North
Carolina, South Carolina, Tennessee and Virginia), and
these two regions were compared to all other states.
Comparison of seroprevalence between two geographic
regions, as well as comparisons between groups of dogs,
was made using the Chi-square test (P <0 . 0 5c o n s i d e r e d
significant) while a one-way ANOVA with significance
assigned at P < 0.05 was used for comparisons of 3 or
more regions. Rates of HME per million in the popula-
tion were calculated based upon the reported cases per
state for the years 2008-2009 divided by the U.S. census
data per state for the same years. Comparison of HME
rates to Ehrlichia spp. seroprevalence was performed
using a linear regression for those states with at least 50
canine samples and the coefficient of determination (R
2 )
was calculated. Analyses were performed using GraphPad
Prism v.5 (GraphPad Software, La Jolla, CA).
Results
The 8,662 canine serum samples originated from dogs in
41 states, with more than 600 samples from each of the
states of Texas, Florida, Missouri and Georgia (Table 1).
Many universities enrolled in the study collected at least
300 samples with the most being submitted by the Uni-
versity of Florida (Table 2). The average age of the dogs
sampled was 6.6 years (range 0.5 - 23 years). The average
age of dogs residing in shelters was younger (3.4 years)
than the other dogs sampled (7.0 years) as was the age of
dogs tested for brucellosis (3.1 years).
Of the 8,662 samples tested, 618 (7.1%) were deter-
mined to have antibodies to at least one of the three Ehr-
lichia species. Antibodies to E. canis, E. chaffeensis or
E. ewingii were detected in 71 (0.8%), 240 (2.8%) and 439
(5.1%) samples, respectively (Table 1). In 132 samples,
antibodies to more than one Ehrlichia species were
detected. The majority of these co-exposed dogs had
antibodies to both E. ewingii and E. chaffeensis (121/132;
92%). Seven dogs had antibodies to E. ewingii and
E. canis,3d o g sh a da n t i b o d i e st oE. canis and E. chaf-
feensis and only one dog was found to have antibodies to
all three Ehrlichia species. Dogs with antibodies to
E. chaffeensis were significantly more likely to have
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tive for E. chaffeensis (P < 0.0001) or dogs seropositive
for E. canis (P = 0.0051).
At least one seroreactive sample was identified from
each of 25 states, and seroreactivity for at least 2 of the 3
Ehrlichia species was found in samples from 22 states
(Figure 1). The region expected to have the greatest R.
sanguineus tick pressure (Alabama, Arkansas, Florida,
Georgia, Louisiana, Mississippi, North Carolina, Okla-
homa, South Carolina, Tennessee and Texas) did not
Table 1 Distribution of canine samples by state and Ehrlichia spp. seroprevalence relative to reported cases of HME.
State Total Number Samples Total Ehrlichia (%) E. canis
(%)
E. ewingii (%) E. chaffeensis (%) HME cases/M*
Alaska 2 0 0 0 0 N
Alabama 337 15 (4.5) 1 (0.3) 12 (3.6) 5 (1.5) 1.8
Arkansas 84 37 (44.0) 3 (3.6) 31 (36.9) 18 (21.4) 21.7
Arizona 1 0 0 0 0 0
California 5 0 0 0 0 0.04
Colorado 5 0 0 0 0 N
Connecticut 97 0 0 0 0 0.3
Delaware 27 0 0 0 0 23.3
Florida 733 27 (3.7) 4 (0.5) 19 (2.6) 9 (1.2) 0.6
Georgia 662 51 (7.7) 1 (0.2) 36 (5.4) 23 (3.5) 1.9
Hawaii 2 0 0 0 0 N
Iowa 14 0 0 0 0 N
Illinois 489 17 (3.5) 0 8 (1.6) 9 (1.8) 2.4
Indiana 553 4 (0.7) 0 4 (0.7) 3 (0.5) 0.3
Kansas 457 35 (7.7) 4 (0.9) 31 (6.8) 5 (1.1) 1.1
Kentucky 16 3 (18.8) 1 (6.3) 3 (18.8) 0 2.9
Louisiana 274 6 (2.2) 4 (1.5) 2 (0.7) 0 0
Massachusetts 241 2 (0.8) 0 2 (0.8) 2 (0.8) 2.3
Maryland 254 16 (6.3) 2 (0.8) 9 (3.5) 9 (3.5) 8.3
Maine 13 0 0 0 0 0.8
Michigan 9 0 0 0 0 0.5
Minnesota 7 0 0 0 0 2.1
Missouri 663 190 (29) 5 (0.8) 151 (22.8) 85 (12.8) 28.4
Mississippi 151 9 (6.0) 0 9 (6.0) 2 (1.3) 1.0
Montana 1 0 0 0 0 N
North Carolina 403 41 (10.2) 3 (0.7) 21 (5.2) 23 (5.7) 4.7
Nebraska 62 1 1 (1.6) 0 0 1.4
New Hampshire 28 0 0 0 0 4.2
New Jersey 257 10 (3.9) 1 (0.4) 7 (2.7) 5 (1.9) 9.0
New York 188 3 (1.6) 0 3 (1.6) 1 (0.5) 3.7
Ohio 428 5 (1.2) 4 (0.9) 1 (0.2) 0 1.0
Oklahoma 514 47 (9.1) 9 (1.8) 37 (7.2) 5 (1.0) 33.2
Pennsylvania 96 1 (1.0) 0 1 (1.0) 0 0.7
Rhode Island 24 0 0 0 0 9.0
South Carolina 34 7 (20.6) 3 (8.8) 2 (5.9) 3 (8.8) 0.3
South Dakota 2 0 0 0 0 0
Tennessee 181 18 (9.9) 5 (2.8) 14 (7.7) 5 (2.8) 10.9
Texas 893 23 (2.6) 18 (2.0) 5 (0.6) 1 (0.1) 0.7
Virginia 385 48 (12.5) 2 (0.5) 31 (8.1) 25 (6.5) 8.4
Wisconsin 9 0 0 0 0 4.0
West Virginia 30 1 0 0 1 (3.3) 0.3
Unknown 31 1 0 0 1
Total 8662 618 (7.1) 71 (0.8) 439 (5.1) 240 (2.8)
*Average incidence of HME cases per million as reported for 2008 and 2009 by passive surveillance; MMWR June 25, 2010 (2008) and May 13, 2011 (2009) (N -
not reported)
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Location Number of samples tested Average patient age (yrs)
Auburn University 538 7.2
University of Florida 645 8.3
University of Georgia 514 8.0
University of Illinois 425 8.0
Kansas State University 521 7.4
Louisiana State University 307 3.7
Mississippi State University 182 7.0
University of Missouri 614 8.0
North Carolina State University 500 7.1
Oklahoma State University 503 3.1
The Ohio State University 501 NA
Purdue University 609 8.2
Texas A&M University 381 3.1
University of Tennessee 108 6.2
Private Veterinary Clinics (6) 314 6.1
Commercial Laboratories (4) 2000 7.0
(NA = not available)
Figure 1 Seroprevalence by state of all three Ehrlichia spp., E. canis, E. chaffeensis and E. ewingii, in dogs.
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(1.2%) compared to all other states combined (0.5%; P =
0.07) (Figure 2). However, the central portion (Arkansas,
Louisiana, Oklahoma, Tennessee, Texas) of this region
had significantly more samples seroreactive for E. canis
than the eastern portion (Alabama, Florida, Georgia, Mis-
sissippi, North Carolina, South Carolina) of this region
(2.0% vs. 0.5% respectively; P= 0.0121). Coincident with
A. americanum distribution, seroreactivity to E. chaffeen-
sis (Figures 3, 4) was 6.6% in the central region (Arkan-
sas, Kansas, Missouri, and Oklahoma) and 4.6% in the
southeast region (Georgia, Maryland, North Carolina,
South Carolina, Tennessee and Virginia). Seroprevalence
of E. chaffeensis in both of these A. americanum indigen-
ous regions was significantly higher than the seropreva-
lence from all other states combined (0.7%; P < 0.0001).
However, seroreactivity to E. ewingii (14.6%) was signifi-
cantly higher in the central region compared with the
seroprevalence in the southeastern region (5.9%) and
when compared to all other states combined (1.4%; P <
0.0001) (Figures 3, 4).
To determine if the seroprevalence of E. chaffeensis and
E. ewingii in dogs might correlate with the number of
HME cases reported per 1,000,000 in the human popula-
tion, a linear regression was performed on the data. If
samples from all states were included, the coefficient of
determination (R
2) was only 0.47 and 0.37 for E. ewingii
and E. chaffeensis, respectively. However, when the sam-
ples from dogs with significantly lower average age (those
from LSU, OKSU, TAMU) were omitted from the analy-
sis, the coefficient of determination increased to 0.72 and
0.73 for E. ewingii and E. chaffeensis, respectively (Figure
5). There was a significant correlation between HME cases
reported per million people and seroprevalence of E. ewin-
gii and E. chaffeensis in dogs (P < 0.0001) but not with ser-
oprevalence of E. canis in dogs (P = 0.704).
E. canis IFA results were compared with that of the Ehr-
lichia species-specific ELISAs for 249 samples obtained
from the NCSU-VBDDL. E. canis IFA identified 5 seropo-
sitive samples with titers of greater than or equal to 1:64.
The Ehrlichia species ELISAs identified the same 5 sam-
ples as seropositive with 3 seroreactive for E. canis,o n e
seroreactive for E. chaffeensis, and one seropositive for
both E. chaffeensis and E. ewingii. The peptide ELISAs
detected 20 additional Ehrlichia seroreactive samples
within the group that had been negative by E. canis IFA.
Figure 2 Seroprevalence by state of E. canis in dogs.
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remainder had detectable antibodies to E. chaffeensis, E.
ewingii, or both (Table 3). In this sample set, the E. canis
IFA did not detect the E. ewingii-only seroreactive samples
(n = 7) identified by the species-specific peptide ELISA.
Discussion
This study evaluated the exposure of dogs to three Ehrli-
chia species, with a particular focus on dogs from the
south and central regions of the U.S., using peptide-based
species-specific ELISA assays. Based on this study, dogs
Figure 3 Seroprevalence by state of E. chaffeensis (green) and E. ewingii (purple) in dogs.
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dies identified in 5.1% of all samples tested. Antibodies to
E. chaffeensis were identified in 2.8% of dogs tested. This
predominance of E. ewingii infection in dogs has been
reported previously in studies from Missouri, Arkansas,
and Oklahoma [4,10]; the present study confirms and
extends that finding over a much wider geographic area.
Antibodies to E. ewingii and E. chaffeensis were identified
in dogs from 23 and 20 of the 41 states considered, respec-
tively, suggesting a widespread distribution of these agents
in the eastern U.S. This pattern parallels the distribution
and intensity of A. americanum ticks in nature [35].
Further, it is consistent with data derived by less specific
serologic assays using sera from deer and dogs [25,35,36].
Figure 4 Seroprevalence by county of E. chaffeensis (green) and E. ewingii (purple) in dogs for the mid-Atlantic, southeastern and
central regions of the U.S.. A black dot indicates that at least one seroreactive sample was identified in that county.
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E. ewingii seroreactive dogs in the present study is also
largely consistent with reports of HME or E. ewingii
infections in people (see Table 1). However, the correla-
tion with HME was not identified unless the institutions
with a biased selection of young dogs in the population
(shelter and kennel/breeder dogs) were excluded from
the analysis suggesting that canine exposure may be
influenced by the time spent in an endemic environment.
A review of individual states revealed some instances
where the E. chaffeensis and E. ewingii seroprevalence in
dogs exceeded the reported number of HME cases in
people. For instance, E. chaffeensis and E. ewingii were
identified in approximately the same proportion of dogs
tested from Kansas (1.1%; 6.8%) and Mississippi (1.3%;
6 . 0 % )a sf r o mT e n n e s s e e( 2 . 8 % ;7 . 7 % )b u tn oc a s e so f
HME were reported from Kansas or Mississippi in 2008
whereas 64 HME cases were reported in people from
Tennessee in that year [37]. Results from 2009 show an
increase in the number of HME cases in Kansas and
Mississippi, with each reporting 6 clinical cases, while 73
were reported from Tennessee [7]. Disease reporting
often varies from year to year, and underreporting of
HME is thought to commonly occur [5]. Alternatively,
infection with other Ehrlichia spp. may be responsible for
the high number of HME patients reported from regions
with low canine seroprevalence as novel Ehrlichia spp.
continue to be described [38-40].
Interestingly, 121 (1.4%) dogs in the present study had
antibodies to both E. ewingii and E. chaffeensis,s u g g e s t -
ing some degree of simultaneous or sequential infection
with these two agents, both of which are transmitted pri-
marily by A. americanum ticks. Co-infection in dogs with
multiple Ehrlichia spp. has been reported from Missouri
and North Carolina, based upon molecular methods
[10,34]. Human co-infection with E. chaffeensis and
E. ewingii has not been reported, but the findings from
the present study, the shared vector tick, and the inability
to distinguish infections with these two agents by less
specific serologic techniques, such as IFA, suggests co-
infection should be considered in people, particularly
when more severe disease is evident. Experimental infec-
tion with multiple rickettsial agents in dogs has been
shown to lead to more severe disease than infection with
a single pathogen [41].
E. canis is a well recognized tick-borne pathogen of dogs
known to cause monocytic ehrlichiosis. In this study expo-
sure to E. canis was highest in the region of Texas, Louisi-
ana, Arkansas and Oklahoma, which is consistent with the
density of the primary tick vector, R. sanguineus. However,
the overall seroprevalence of E. canis was much lower
compared to the seroprevalence of E. chaffeensis and
E. ewingii, which may be consistent with the increase in
A. americanum numbers and expanding geographic distri-
bution of this tick species [5]. Additionally, previous sero-
surveys which have utilized methods like E. canis IFA or
the SNAP
®3Dx
® or SNAP
®4Dx
® test kits to measure
E. canis seroprevalence may have detected ehrlichial anti-
bodies other than those specific for E. canis resulting in an
overestimate of E. canis exposure [23,42]. This differs
from the present study which utilized a peptide that is spe-
cific for E. canis and does not detect antibodies to E. chaf-
feensis or E. ewingii [32]. Finally, the advent of more
efficacious and long-acting acaracides could be having an
impact on E. canis exposure rates in dogs due to the
resulting suppression of the natural maintenance cycle for
E. canis. Both the greater host specificity of R. sanguineus
ticks relative to A. americanum and the lack of wildlife
reservoir for E. canis favor a suppression of the natural
maintenance cycle for E. canis relative to E. chaffeensis
and E. ewingii. No such suppression of A. americanum
maintenance cycles in deer or other wildlife inhabiting
natural environments would be expected to be ongoing
currently.
Figure 5 Correlation between the average number of reported
cases of HME/million people by state and seroprevalence for
E. chaffeensis (grey) and E. ewingii (black) in dogs by state.
Analysis excluded HME rates and canine seroprevalence from those
states where the veterinary institutions had a biased collection of
samples from young dogs within the population.
Table 3 Comparison of serologic results using E.canis IFA
and the three Ehrlichia species ELISAs
Ehrlichia species by ELISA: E. canis IFA/Ehrlichia species ELISAs
Pos/Neg Pos/Pos Neg/Pos Neg/Neg
E. canis 032
E. ewingii 007
E. chaffeensis 016
E. ewingii + E. chaffeensis 015
Total 0 5 20 224
A total of 249 serum samples from the VBDDL at NCSU had previously been
tested by E. canis IFA. Titers of 1:64 and greater were considered positive.
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Page 9 of 11In addition to the results of this study, results from pre-
vious experimental infection studies with E. chaffeensis
and E. ewingii [32] as well as regional field studies [4]
have demonstrated the sensitivity and specificity of these
peptide reagents for antibody detection in infected canine
samples. To further evaluate the performance, a limited
number of samples were used to compare the results of
the three Ehrlichia ELISAs with E. canis IFA as per-
formed by the NCSU VBDDL. When compared to
E. canis IFA, 20/249 samples (8%) were reactive on the
species-specific ELISAs that did not demonstrate reactiv-
ity by IFA testing. Results of a previous study demon-
strated that up to 8% of samples with reactivity to
Ehrlichia species peptide reagents on SNAP 3Dx (p30/
p30-1) may test negative (titers < 1:64) on E. canis IFA
[23]. The identification of samples having antibodies to
E. chaffeensis and/or E. ewingii by ELISA but not con-
firmed positive by E. canis IFA may reflect the variability
of cross-reactive antibodies between these Ehrlichia spe-
cies. Differences in assay format between ELISA and IFA,
such as testing a less dilute serum sample and the use of
highly concentrated immunodominant epitopes on the
ELISA, may account for some of the observed differences.
More studies are needed to determine the degree with
which cross-reacting antibodies in dogs exposed to
E. chaffeensis and E. ewingii will react with E. canis IFA,
the primary Ehrlichia species used as antigen in IFA test-
ing by veterinary diagnostic laboratories.
Conclusions
In this study, we documented that dogs in the central and
south central U.S. are more commonly exposed to E. ewin-
gii than other ehrlichial species, and are more commonly
exposed to E. chaffeensis than to E. canis.I nt h ec a s eo f
E. chaffeensis and E. ewingii, the lone star tick transmits
these infectious agents to both dogs and people. The dog
has been described as a sentinel for vector-borne infec-
tions like Lyme Disease and Rocky Mountain Spotted
Fever [29,43-45]. The results of this study provide preli-
minary evidence that dogs can be tested using Ehrlichia
species-specific peptides and serve as a regional or local
sentinel to gauge the potential risk for human infection
with these tick-transmitted pathogens.
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